Emily E. Weber LeBrun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emily E. Weber LeBrun has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Stephen B. Young
Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, University of Massachusetts Memorial Medical Center, Worcester, MA
4 shared publications- Alexandra D. Hernandez
University of Florida College of Medicine, Gainesville, FL
2 shared publications Amos Adelowo
From the Division of Urogynecology, Department of Obstetrics and Gynecology, University of Massachusetts Memorial Medical Center, Worcester, Massachusetts
2 shared publicationsAnthony G. Visco
2 shared publications- Catherine S. Bradley
Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USA
2 shared publications - Christina Raker
Division of Kidney Disease and Hypertension, Department of Medicine, Rhode Island Hospital, Providence, Rhode Island
2 shared publications
Latest Publications
- Open Access
- 8 February 2023
- Published by Springer Nature in Cureus
- Vol. 15 (2) , e34776
Retention of a Foreign Body in the Vagina of an Adult for 13 Years: A Case Report
Cases in which foreign bodies have been inserted into the vagina predominately occur in the pediatric population. This report presents the case of an adult woman with a retained foreign body for 13 years. A duplicated ureter suggestive of a Mullerian anomaly was incidentally identified on intraoperative cystoscopy. Mullerian anomalies may be associated with complex patient presentations and are associated with reproductive implications that should be discussed based on patient-specific characteristics.
- 8 February 2023
- Published by Springer Nature in Cureus
- Vol. 15 (2) , e34776
Open AccessRetention of a Foreign Body in the Vagina of an Adult for 13 Years: A Case Report
Cases in which foreign bodies have been inserted into the vagina predominately occur in the pediatric population. This report presents the case of an adult woman with a retained foreign body for 13 years. A duplicated ureter suggestive of a Mullerian anomaly was incidentally identified on intraoperative cystoscopy. Mullerian anomalies may be associated with complex patient presentations and are associated with reproductive implications that should be discussed based on patient-specific characteristics.
- Open Access
- 1 June 2021
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 224 (6) , S797-S798
86 Patient perception of “elective” versus “non-elective” surgery during the COVID-19 pandemic
- 1 June 2021
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 224 (6) , S797-S798
Open Access86 Patient perception of “elective” versus “non-elective” surgery during the COVID-19 pandemic
- 1 June 2021
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 224 (6) , S807
107 Obtaining healthcare news during the COVID-19 pandemic: Does age influence source selection in gynecology patients?
- 1 June 2021
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 224 (6) , S807
107 Obtaining healthcare news during the COVID-19 pandemic: Does age influence source selection in gynecology patients?
- 1 July 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 223 (1) , 85.e1-85.e19
Coronavirus disease 2019 pandemic: staged management of surgical services for gynecology and obstetrics
- 1 July 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 223 (1) , 85.e1-85.e19
Coronavirus disease 2019 pandemic: staged management of surgical services for gynecology and obstetrics
- 18 August 2017
- Published by Springer Nature in Current Obstetrics and Gynecology Reports
- Vol. 6 (4) , 249-256
Update on Surgical Treatments for Pelvic Organ Prolapse
- 18 August 2017
- Published by Springer Nature in Current Obstetrics and Gynecology Reports
- Vol. 6 (4) , 249-256
Update on Surgical Treatments for Pelvic Organ Prolapse
- 1 September 2016
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 22 (5) , 364-368
Comparison of Perioperative Complications by Route of Hysterectomy Performed for Benign Conditions
Objective: The aim of this study was to compare perioperative complications by route of hysterectomy before and after the introduction of robotic surgery. Methods: This is an ancillary analysis of a multicenter, retrospective cohort study with historical controls through the Fellows’ Pelvic Research Network. Hysterectomies performed for benign conditions were collected prior to introduction of the robot (prerobot) and the year after introduction of the robot (postrobot) at each institution. To obtain a representative annual case distribution for each institution, a maximum of 20 cases per month were selected using stratified random sampling. Patient demographics and intraoperative and postoperative complication data were collected. Results: One thousand four hundred forty cases were included in this study, 732 in the prerobot and 708 in the postrobot period. Intraoperative complications in the prerobot group were highest in the abdominal group (7.4%) followed by vaginal (3.9%) and laparoscopic (3.7%) groups. Postoperative complications were higher in the vaginal (8.3%) and abdominal (7.4%) groups compared with laparoscopic (1.8%) groups (P = 0.03), because of a higher proportion of infections. In the postrobot period, intraoperative complications were lower in the vaginal (2.8%), robotic (3%), and laparoscopic (4.6%) groups compared with abdominal (10.8%) (P = 0.04). Postoperative complications were lowest in the vaginal (5.1%), laparoscopic (3.6%), and robotic (3%) approaches compared with the abdominal (13.9%) approach (P = 0.003). Conclusions: Vaginal hysterectomy has comparable rates of perioperative complications when compared with robotic and laparoscopic approaches and should be considered as a primary surgical approach in the growing armamentarium of minimally invasive approaches for hysterectomy for benign conditions.
- 1 September 2016
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 22 (5) , 364-368
Comparison of Perioperative Complications by Route of Hysterectomy Performed for Benign Conditions
Objective: The aim of this study was to compare perioperative complications by route of hysterectomy before and after the introduction of robotic surgery. Methods: This is an ancillary analysis of a multicenter, retrospective cohort study with historical controls through the Fellows’ Pelvic Research Network. Hysterectomies performed for benign conditions were collected prior to introduction of the robot (prerobot) and the year after introduction of the robot (postrobot) at each institution. To obtain a representative annual case distribution for each institution, a maximum of 20 cases per month were selected using stratified random sampling. Patient demographics and intraoperative and postoperative complication data were collected. Results: One thousand four hundred forty cases were included in this study, 732 in the prerobot and 708 in the postrobot period. Intraoperative complications in the prerobot group were highest in the abdominal group (7.4%) followed by vaginal (3.9%) and laparoscopic (3.7%) groups. Postoperative complications were higher in the vaginal (8.3%) and abdominal (7.4%) groups compared with laparoscopic (1.8%) groups (P = 0.03), because of a higher proportion of infections. In the postrobot period, intraoperative complications were lower in the vaginal (2.8%), robotic (3%), and laparoscopic (4.6%) groups compared with abdominal (10.8%) (P = 0.04). Postoperative complications were lowest in the vaginal (5.1%), laparoscopic (3.6%), and robotic (3%) approaches compared with the abdominal (13.9%) approach (P = 0.003). Conclusions: Vaginal hysterectomy has comparable rates of perioperative complications when compared with robotic and laparoscopic approaches and should be considered as a primary surgical approach in the growing armamentarium of minimally invasive approaches for hysterectomy for benign conditions.
- 1 March 2016
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 43 (1) , 121-130
Registries as Tools for Clinical Excellence and the Development of the Pelvic Floor Disorders Registry
- 1 March 2016
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 43 (1) , 121-130
Registries as Tools for Clinical Excellence and the Development of the Pelvic Floor Disorders Registry
- 1 March 2016
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 22 (2) , 77-82
The Pelvic Floor Disorders Registry
Pelvic organ prolapse (POP) is a common problem that negatively impacts women's quality of life. A variety of surgeries exist for POP treatment, including procedures performed with and without mesh augmentation. The growing use of mesh in prolapse surgeries in the 2000s was associated with increasing reports of complications, resulting in Food and Drug Administration (FDA) Safety Notifications, and in 2012, the FDA ordered transvaginal mesh manufacturers to conduct prospective studies to evaluate longer-term outcomes. These requirements provided incentives and an environment conducive to collaboration. American Urogynecologic Society leaders collaborated with device manufacturers, the FDA, and other professional organizations to establish the Pelvic Floor Disorders Registry (PFDR), a collection of interrelated registries, which could meet manufacturers' needs but also allow surgeons to track individual and aggregate outcomes for quality improvement. The PFDR was developed and launched by American Urogynecologic Society with objectives of (1) collecting, storing, and analyzing clinical data related to POP treatment; (2) establishing common data elements and quality metrics; and (3) providing a framework for external stakeholders to conduct POP research. The PFDR includes industry-sponsored studies, as well as 2 options for volunteer registry participation, the PFDR-Quality Improvement and PFDR-Research. The PFDR promotes quality improvement and national benchmarking and will provide real-world comparative safety and effectiveness data for prolapse surgeries. The PFDR can serve as a model for collaboration between medical practitioners, researchers, industry, and federal agencies and may allow progress toward our similar goal of high-quality surgical care of women with prolapse.
- 1 March 2016
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 22 (2) , 77-82
The Pelvic Floor Disorders Registry
Pelvic organ prolapse (POP) is a common problem that negatively impacts women's quality of life. A variety of surgeries exist for POP treatment, including procedures performed with and without mesh augmentation. The growing use of mesh in prolapse surgeries in the 2000s was associated with increasing reports of complications, resulting in Food and Drug Administration (FDA) Safety Notifications, and in 2012, the FDA ordered transvaginal mesh manufacturers to conduct prospective studies to evaluate longer-term outcomes. These requirements provided incentives and an environment conducive to collaboration. American Urogynecologic Society leaders collaborated with device manufacturers, the FDA, and other professional organizations to establish the Pelvic Floor Disorders Registry (PFDR), a collection of interrelated registries, which could meet manufacturers' needs but also allow surgeons to track individual and aggregate outcomes for quality improvement. The PFDR was developed and launched by American Urogynecologic Society with objectives of (1) collecting, storing, and analyzing clinical data related to POP treatment; (2) establishing common data elements and quality metrics; and (3) providing a framework for external stakeholders to conduct POP research. The PFDR includes industry-sponsored studies, as well as 2 options for volunteer registry participation, the PFDR-Quality Improvement and PFDR-Research. The PFDR promotes quality improvement and national benchmarking and will provide real-world comparative safety and effectiveness data for prolapse surgeries. The PFDR can serve as a model for collaboration between medical practitioners, researchers, industry, and federal agencies and may allow progress toward our similar goal of high-quality surgical care of women with prolapse.
- 1 March 2016
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 22 (2) , 70-76
Pelvic Floor Disorders Registry
Pelvic floor disorders affect up to 24% of adult women in the United States, and many patients with pelvic organ prolapse (POP) choose to undergo surgical repair to improve their quality of life. While a variety of surgical repair approaches and techniques are utilized, including mesh augmentation, there is limited comparative effectiveness and safety outcome data guiding best practice. In conjunction with device manufacturers, federal regulatory organizations, and professional societies, the American Urogynecologic Society developed the Pelvic Floor Disorders Registry (PFDR) designed to improve the quality of POP surgery by facilitating quality improvement and research on POP treatments. The PFDR will serve as a resource for surgeons interested in benchmarking and outcomes data and as a data repository for Food and Drug Administration-mandated POP surgical device studies. Provider-reported clinical data and patient-reported outcomes will be collected prospectively at baseline and for up to 3 years after treatment. All data elements including measures of success, adverse events, and surgeon characteristics were identified and defined within the context of the anticipated multifunctionality of the registry, and with collaboration from multiple stakeholders. The PFDR will provide a platform to collect high-quality, standardized patient-level data from a variety of nonsurgical (pessary) and surgical treatments of POP and other pelvic floor disorders. Data from this registry may be used to evaluate short- and longer-term treatment outcomes, patient-reported outcomes, and complications, as well as to identify factors associated with treatment success and failure with the overall goal of improving the quality of care for women with these conditions.
- 1 March 2016
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 22 (2) , 70-76
Pelvic Floor Disorders Registry
Pelvic floor disorders affect up to 24% of adult women in the United States, and many patients with pelvic organ prolapse (POP) choose to undergo surgical repair to improve their quality of life. While a variety of surgical repair approaches and techniques are utilized, including mesh augmentation, there is limited comparative effectiveness and safety outcome data guiding best practice. In conjunction with device manufacturers, federal regulatory organizations, and professional societies, the American Urogynecologic Society developed the Pelvic Floor Disorders Registry (PFDR) designed to improve the quality of POP surgery by facilitating quality improvement and research on POP treatments. The PFDR will serve as a resource for surgeons interested in benchmarking and outcomes data and as a data repository for Food and Drug Administration-mandated POP surgical device studies. Provider-reported clinical data and patient-reported outcomes will be collected prospectively at baseline and for up to 3 years after treatment. All data elements including measures of success, adverse events, and surgeon characteristics were identified and defined within the context of the anticipated multifunctionality of the registry, and with collaboration from multiple stakeholders. The PFDR will provide a platform to collect high-quality, standardized patient-level data from a variety of nonsurgical (pessary) and surgical treatments of POP and other pelvic floor disorders. Data from this registry may be used to evaluate short- and longer-term treatment outcomes, patient-reported outcomes, and complications, as well as to identify factors associated with treatment success and failure with the overall goal of improving the quality of care for women with these conditions.
- 1 February 2016
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 127 (2) , 400
Flutter, Flutter
- 1 February 2016
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 127 (2) , 400
Flutter, Flutter